NUTRACEUTICAL AND PHARMACOLOGICAL INTERVENTION IN NEUROLOGICAL DISORDERS
Dr Virginie Lam, Research Fellow
Curtin Medical Research Institute, Curtin University &
Perron Institute for Neurological and Translational Science
Perth, Western Australia
RESEARCHER PROFILE
Filmed in Perth, Australia | August 2025
Dr Virginie Lam is a neuroscientist and cerebrovascular biologist with over 15 years of research experience, including more than seven years post-PhD. She co-leads the Neurovascular and Metabolic Diseases Laboratory at the Curtin Medical Research Institute and holds an affiliate appointment at the Perron Institute for Neurological and Translational Science. Her research focuses on the interface between neurovascular health, cognitive function, and therapeutic translation in neurodegenerative disorders.
Dr Lam is the scientific project manager and co-investigator of a Medical Research Future Fund (MRFF)-supported Phase II randomised controlled trial in Alzheimer’s disease. She has led the expansion of this study into a multi-site trial involving centres across Western Australia, Tasmania, South Australia, Queensland, and New South Wales. She also established the trial’s first international collaboration in New Zealand, supporting a trans-Tasman research network across academic, hospital, and clinical trial partners.
Dr Lam has secured over AUD$6 million in competitive research funding as chief investigator, including grants from the MRFF, NHMRC, Raine Foundation, WA Future Health Research and Innovation Fund, and the Bryant Stokes Neurological Research Fund. Her expertise spans clinical trial coordination, human research ethics, neuroimaging, cognitive assessment, and the translation of preclinical findings into early-phase interventions. She has authored more than 70 peer-reviewed publications and currently leads a multidisciplinary team of scientists, clinicians, and research personnel.
She serves on the National Imaging Facility (WA Node) Advisory Board, Curtin University’s human and animal research ethics committee, and multiple NHMRC peer review panels. Dr Lam is actively engaged in research governance and capacity building, having founded and co-chaired several early-to-mid-career researcher (EMCR) committees and national working groups. Her research program continues to inform the development of targeted therapeutic strategies for neurovascular and cognitive disorders through rigorous translational science and cross-sector collaboration.
Source: Supplied
https://orcid.org/0000-0001-8463-645X
-
Cellular mechanisms of traumatic brain injury & concussion
Professor Melinda Fitzgerald is Deputy Vice Chancellor, Research at Curtin University, John Curtin Distinguished Professor and CEO of Connectivity Traumatic Brain Injury Australia.
She has published over 135 papers; recent highlights include Lancet Neurology, J Neuroscience, Nature Nano, ACS Nano, Biomaterials. Currently held grants/Projects total $10.1 million; CIA for $5.2 million of these; $18.5 million total research and equipment funding, $9.9 million as CIA; continuous category 1 grant funding as CIA since 2009.
-
In his father’s footsteps as a kidney transplant specialist
Since he was a young child, Dr Collins, has been interested in kidney failure and kidney transplants in particular. His father was also a kidney specialist, and he used to sit by the phone when his father, was on call and ringing people who were being offered a kidney transplant. The joy in their voices through this interaction created a lasting and profound impact on Dr Collins. This carried through his career and today he continues to seek better outcomes for Kidney patients.
-
Good and bad extracellular vesicles in health and disease
Associate Professor Joy Wolfram has joint appointments in the School of Chemical Engineering and the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland, and through her work at the AIBN, she aims to develop a new paradigm of therapeutics (using nanotechnology and cell products) to treat life-threatening diseases that are major causes of death globally, including cardiovascular disease, kidney disease, and breast cancer.
